900
Participants
Start Date
November 30, 2001
Primary Completion Date
November 30, 2004
Study Completion Date
January 31, 2005
Natalizumab
Natalizumab 300 mg IV infusion, every 4 weeks, for up to 116 weeks.
Placebo
Placebo, IV infusion, every 4 weeks, for up to 116 weeks.
National MS Centrum, Melsbroek
LUC- University Centre, Diepenbeek
Algemeen Ziekenhuis St. Jan, Bruges
Hopital de la Timone, Service de Neurologie, Marseille
Lehigh Valley Hospital, Neurosciences Research, Allentown
University of Miami School of Medicine, Department of Neurology, Miami
CHRU - Hopital de Pontchaillou, Service de Neurologie, Rennes
St. Josef-Hospital, Neurologische Klinik der Ruhruniversitat Bochum, Bochurn
Michigan Institute for Neurological Disorders, Farmington Hills
Faculty Hospital Brno Bohunice, Brno
University of Kansas Medical Center, Department of Neurology, Kansas City
University of Nebraska Medical Center, Omaha
Faculty Hospital Of Ostrava Poruba, Ostrava
Texas Neurology, Dallas
Mayo Clinic Scottsdale, Scottsdale
CMRRC, Albuquerque
East Bay Region Associates in Neurology, Berkeley
University of Washington MS Research Center, Seattle
UC Davis School of Medicine, Department of Neurology, Davis
Yale University School of Medicine, Department of Neurology, New Haven
Gimbel MS Center, Teaneck
Oregon Health Sciences University, Department of Neurology, Portland
Vancouver Hospital and Health Sciences Center UBC Pavilion, MS Clinical Research Group, Vancouver
Health Services Centre, Winnipeg
Kingston General Hospital, Neurology, Kingston
University Hospital, London
Sunnybrook and Women's College and Health Science Centre, Toronto
University of Toronto, MS Clinic, St. Michael's Hospital, Toronto
CHVO Hull Hospital, Québec
MS Research Unit, Center for Clinical Research, Halifax
Family Medical Centre, Ottawa
Faculty Hospital St. Anne, Brno
Faculty Hospital of Hradec Kralove, Hradec Králové
Faculty Hospital Olomouc, Olomouc
Hospital Pardubice - Department of Neurology, Pardubice
Faculty Hospital Plzen - Clinic of Neurology, Pilsen
General Teaching Hospital - Neurological Department, Prague
Faculty Hospital Motol - Neurological Clinic, Prague
Klinika Neurologii, Bydgoszcz
Academisch Ziekenhuis VU, Amsterdam
Institute of Neurology, Queen Square
The Royal London Hospital, Whitechapel
Atkin's Morely Hospital, Wimbledon
Oldchurch Hospital, Essex
Royal Victoria Infirmary, Newcastle upon Tyne
Ipswich Hospital NHS Trust - Department of Clinical Neurology, Ipswich
St. James University Hospital, Department of Neurology, Leeds
Guy's Hospital, London
King's College Hospital, London
Kings College Hospital, Kings Neuroscience Center, London
The Radcliffe Infirmary, University Department of Clinical Neurology, Oxford
Royal Hallamshire Hospital, Sheffield
North Staffordshire Royal Infirmary - Neurology Department, Stoke-on-Trent
Lead Sponsor
Collaborators (1)
Elan Pharmaceuticals
INDUSTRY
Biogen
INDUSTRY